{"id":14037,"date":"2024-12-18T18:23:48","date_gmt":"2024-12-19T00:23:48","guid":{"rendered":"https:\/\/montecaldera.com\/?p=14037"},"modified":"2024-12-28T20:19:47","modified_gmt":"2024-12-29T02:19:47","slug":"monte-caldera-joins-the-nvidia-inception-program-2","status":"publish","type":"post","link":"https:\/\/montecaldera.com\/?p=14037","title":{"rendered":"MCT Secures Investment from GRIDX to Advance Biotech Innovations"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\n

Miami, FL \u2013 Nov 15, 2024:<\/strong> Monte Caldera Technologies Inc., a pioneer in materials discovery through the innovative NESCGLE framework, is proud to announce its latest achievement: securing investment from GRIDX VC, a renowned deep-tech venture capital fund and leader in the Biotech VC ecosystem. This partnership is set to accelerate the development and application of NESCGLE-based solutions in the Biotech and Pharma sectors.<\/p>\n

Monte Caldera\u2019s journey with GRIDX began when the startup was selected to participate in the prestigious GRIDX Ignite Acceleration Program<\/strong>. Out of more than 400 startups vying for a spot, Monte Caldera stood out, advancing to the “Build” phase with only 20 other companies. Following rigorous evaluation and development, Monte Caldera earned its place among the elite startups receiving investment and is now an integral part of the exclusive GRIDX portfolio.<\/p>\n

This investment marks a significant milestone for Monte Caldera Technologies, enabling the company to drive impactful advancements in Biotech and Pharma. The NESCGLE framework, with its unparalleled predictive modeling capabilities, will now be further developed to tackle industry challenges such as drug formulation, biomaterials design, and scalable production techniques.<\/p>\n

\u201cWe are thrilled to join the GRIDX portfolio and to benefit from their unmatched expertise and support in the deep-tech and biotech spaces,\u201d said Hector Medina, CEO of Monte Caldera Technologies. \u201cThis partnership will amplify our efforts to bring NESCGLE-based innovations to the forefront, shaping the future of Biotech and Pharma.\u201d<\/p>\n

GRIDX VC\u2019s investment reinforces Monte Caldera\u2019s mission to revolutionize material discovery and its applications across industries. This collaboration further positions Monte Caldera as a leader in cutting-edge materials science solutions.<\/p>\n

About Monte Caldera Technologies Inc.<\/strong>
Monte Caldera Technologies is a deep-tech startup focused on accelerating materials discovery and innovation through its NESCGLE theory and modeling framework. By leveraging advanced computational tools, the company is driving transformative breakthroughs across industries such as Biotech, Pharma, Energy, and more.<\/p>\n

About GRIDX (gridexponential.com)<\/strong>
GRIDX (GRID Exponential) is a venture capital fund specializing in deep-tech investments, with a strong presence in the Biotech ecosystem. Through its Ignite Acceleration Program, GRIDX identifies and supports groundbreaking startups poised to make a global impact.<\/p>\n

Contact:<\/strong>
Paulina Ojeda,\u00a0Investors Relations
Monte Caldera Technologies Inc.
info@montecaldera.com<\/a>
montecaldera.com<\/p>\n

###<\/strong><\/p>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Miami, FL \u2013 Nov 15, 2024: Monte Caldera Technologies Inc., a pioneer in materials discovery through the innovative NESCGLE framework, is proud to announce its latest achievement: securing investment from GRIDX VC, a renowned deep-tech venture capital fund and leader…<\/p>\n","protected":false},"author":1,"featured_media":14057,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"link","meta":{"_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[21,33],"tags":[26,27,28,29],"class_list":["post-14037","post","type-post","status-publish","format-link","has-post-thumbnail","hentry","category-news","category-press-releases","tag-biotech","tag-gridx","tag-investors","tag-nescgle","post_format-post-format-link"],"_links":{"self":[{"href":"https:\/\/montecaldera.com\/index.php?rest_route=\/wp\/v2\/posts\/14037","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/montecaldera.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/montecaldera.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/montecaldera.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/montecaldera.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=14037"}],"version-history":[{"count":5,"href":"https:\/\/montecaldera.com\/index.php?rest_route=\/wp\/v2\/posts\/14037\/revisions"}],"predecessor-version":[{"id":14048,"href":"https:\/\/montecaldera.com\/index.php?rest_route=\/wp\/v2\/posts\/14037\/revisions\/14048"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/montecaldera.com\/index.php?rest_route=\/wp\/v2\/media\/14057"}],"wp:attachment":[{"href":"https:\/\/montecaldera.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=14037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/montecaldera.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=14037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/montecaldera.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=14037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}